Premier Anti-Aging Co., Ltd.

4934.T
Household & Personal Products
2026/10/28 18:47 Updated
Market Cap: $30.7M (¥4.8B)
Stock Price: $3.52 (¥556)
Exchange Rate: 1 USD = ¥157.98

Matters Concerning the Controlling Shareholder

Discloses matters concerning the controlling shareholder. Lists the name and voting rights ratios of the parent company/controlling shareholder, presence or absence of transactions, and measures to protect minority shareholders. Based on information as of July 31, 2026, Mr. Kiyoshi Matsuura directly holds 21.55% as a controlling shareholder and holds a total of 67.24% of voting rights when aggregated. Future transaction policy and the plan to establish an independent committee are also specified.

Importance:
Page Updated: October 29, 2026
IR Disclosure Date: October 29, 2026

Key Figures

  • Key Figure 1: Voting Rights Ownership Ratio (Direct Ownership) 21.55%
  • Key Figure 2: Voting Rights Ownership Ratio (Aggregated Targets) 45.68%
  • Key Figure 3: Voting Rights Ownership Ratio (Total) 67.24%

AI要約

Disclosure of Controlling Shareholder Information

This document summarizes the disclosure of matters concerning the controlling shareholder as of July 31, 2026. Mr. Kiyoshi Matsuura holds 21.55% directly as a controlling shareholder, and a total of 67.24% of voting rights when including aggregated targets such as asset management companies. The purpose of the disclosure is to clarify measures to protect minority shareholders and to ensure transaction transparency. If a transaction is likely to occur, the board of directors will consider the reasons, necessity, and terms of the transaction, and deliberation by a special committee including independent outside directors is planned.

Future Responses and Minority Shareholder Protection

If conflicts of interest arise between the controlling shareholder and minority shareholders, a special committee will be established to deliberate and consider the matter, and appropriate measures will be taken to avoid infringing on minority shareholder rights. No transactions with the controlling shareholder have occurred to date, and in principle no transactions are planned in the future; however, if operational necessity arises, decisions will be made after appropriate disclosure and review.

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.

Premier Anti-Aging Co., Ltd.

Company overview · Stock price · Financial data · All IR

View company page →